510(k) Report

510(k) · Decided

Decided

GlidePath 13F Long-Term Hemodialysis Catheter

K211410510(k) SpecialDecided Jun 4, 202129-day reviewClass II21 CFR 876.5540

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bard Peripheral Vascular, Inc. · MSD Catheter, Hemodialysis, Implanted

Cleared on Jun 4, 2021 as substantially equivalent to K190527 (C. R. Bard, 2020) after a 29-day review. Its family tree reaches back 7 generations to 1998.

Decided
Jun 4, 2021
Review
29 days
Class
Class II
Product code
MSD
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K981994 (1998). 9 ancestors in all, the oldest K972207 (1998). No later device cites it as a predicate yet.

  1. Root · 7 generations backK981994 Vascath Opti-Flow Long Term Dual Lumen Hemodialysis CatheterC.R. Bard, Inc. · 1998
  2. 6 generations backK012562 Medcomp 14.5F Double Lumen Hemodialysis CatheterMedical Components, Inc. · 2002
  3. 5 generations backK020465 Medcomp Ash Split-Cath IIMedcomp · 2002
  4. 4 generations backK030020 Hemosplit Long-Term Hemodialysis CatheterC.R. Bard, Inc. · 2003
  5. 3 generations backK033294 Hemosplit XK, Hemosplit XK Catheter, 16FR X 42 CM, Kit;16FR X 19 CM…C.R. Bard, Inc. · 2003
  6. 2 generations backK051748 Hemoglide Series and Hemoglide Star Series XK Long-Term Hemodialysis…C.R. Bard, Inc. · 2005 · Recalled
  7. 1 generation backK190527 GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term…C. R. Bard · 2020
  8. This deviceK211410 GlidePath 13F Long-Term Hemodialysis CatheterBard Peripheral Vascular, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K981994Vascath Opti-Flow Long Term Dual Lumen Hemodialysis CatheterC.R. Bard, Inc.1998—
−6K012562Medcomp 14.5F Double Lumen Hemodialysis CatheterMedical Components, Inc.2002—
−5K020465Medcomp Ash Split-Cath IIMedcomp2002—
−4K030020Hemosplit Long-Term Hemodialysis CatheterC.R. Bard, Inc.2003—
−3K033294Hemosplit XK, Hemosplit XK Catheter, 16FR X 42 CM, Kit;16FR X 19 CM, Kit with…C.R. Bard, Inc.2003—
−2K051748Hemoglide Series and Hemoglide Star Series XK Long-Term Hemodialysis CathetersC.R. Bard, Inc.200513
−1K190527GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis…C. R. Bard2020—
0 (this device)K211410GlidePath 13F Long-Term Hemodialysis CatheterBard Peripheral Vascular, Inc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
FIG. 1 — Lineage of K211410, 1998–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MSD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MSD device

  1. #1 K241581 Hemodialysis Catheterscore 12.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K190527GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis Catheters…
Summary page 4
…egulation Number: 21 CFR 876.5540 Review Panel: Gastroenterology/Urology Predicate Device: GlidePath™ Long-Term Hemodialysis Catheter (K190527, cleared March 5, 2020) Bard Peripheral Vascular, Inc.…
C. R. Bard2020—

Also cleared against K190527: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 5 companies; a new generation was cleared every 1.2 years on median.
  • 1 of the 9 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K190527.

How does its category compare?

All MSD devices

MSD Catheter, Hemodialysis, Implanted: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · MSD

1in 2025

2007: 72008: 32009: 62010: 42011: 72012: 22013: 52014: 82015: 12016: 22017: 22018: 22019: 12020: 42021: 42025: 1
2007high 8 (2014) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MSD

153in 2021

2007: 92 days median2008: 89 days median2009: 81 days median2010: 116 days median2011: 70 days median2013: 105 days median2014: 246 days median2020: 106 days median2021: 153 days median
2007high 246 (2014) · low 70 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MSD

1in 2013

2008: 472009: 492010: 112011: 242013: 12026 (partial year): 4, 4 Class I
2007high 49 (2009) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · MSD

1,054in 2025

2007: 1182008: 1742009: 1732010: 3062011: 2682012: 3672013: 3632014: 5062015: 5502016: 5322017: 4842018: 4632019: 6452020: 4012021: 5232022: 6102023: 5422024: 8412025: 1,054
2007high 1,054 (2025) · low 118 (2007)2025

MAUDE reports naming product code MSD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077920118
200838947174
200968149173
2010411611306
201177024268
20122—0367
201351051363
201482460506
20151—0550
20162—0532
20172—0484
20182—0463
20191—0645
202041060401
202141530523
20220—0610
20230—0542
20240—0841
20251—01,054
20260—4 (4)—

What is it indicated for?

The GlidePath™ 13F long-term hemodialysis catheters are indicated for use in attaining short-term

or long-term vascular access for hemodialysis, hemoperfusion or apheresis therapy. Access is

attained via the internal jugular vein, subclavian vein, or femoral vein. Catheters longer than

34 cm are intended for femoral vein insertion.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211410: GlidePath 13F Long-Term Hemodialysis Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K211410

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026